tiprankstipranks
Trending News
More News >

Andrew Schutte Insider Profile

4 Followers
Andrew Schutte, Director, Ten Percent Owner at RepliCel Life Sciences, holds 19.37M shares in RepliCel Life Sciences (Ticker: REPCF). Most recently, Andrew Schutte ― shares of RepliCel Life Sciences on ― for an estimated value of ―.
tipranks
Andrew Schutte

Andrew Schutte
RepliCel Life Sciences (REPCF)
Director, Ten Percent Owner

Ranked #84,913 out of 101,378 Corporate Insiders

Profitable Transactions

33%
3 out of 9 Profitable Transactions

Average Return

-18.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$194K
100.00%
A breakdown of Andrew Schutte's holdings

Insider Roles

RepliCel Life Sciences
(REPCF)
Director, Ten Percent Owner
Roles that Andrew Schutte holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Andrew Schutte

Andrew Schutte's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
RepliCel Life Sciences
Director, Ten Percent Owner
$193.70K
Andrew Schutte has not reported any informative transactions for REPCF, therefore, performance cannot be measured.
List of latest transactions for each holding click on a transaction to see Andrew Schutte's performance on stock

Andrew Schutte insider profile FAQ

What is the percentage of profitable transactions made by Andrew Schutte?
The percentage of profitable transactions made by Andrew Schutte is 33%.
    What is the average return per transaction made by Andrew Schutte?
    The average return per transaction made by Andrew Schutte is -18.40%.
      What stocks does Andrew Schutte hold?
      Andrew Schutte holds: REPCF stocks.
        What was Andrew Schutte’s latest transaction?
        Andrew Schutte latest transaction was an Uninformative Buy of ―.
          What was Andrew Schutte's most profitable transaction?
          Andrew Schutte’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Andrew Schutte's role in RepliCel Life Sciences?
            Andrew Schutte's role in RepliCel Life Sciences is Director, Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.